Shanghai MicroPort MedBot Group Co Ltd (2252.HK)

Name: Shanghai MicroPort MedBot Group Co Ltd Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2026-04-07

Latest Quarter

2026-04-07

Revenue

$176M

Net Income

-$113M

Operating Margin

-63.1%

Free Cash Flow

-$340M

Debt / Assets

70.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Income Statement (Quarterly)	2026-04-07	2025-12-31	2025-06-30	2025-03-31
Revenue	175,689,000	369,117,316	175,689,000	87,844,500
Cost of Revenue	104,183,000	232,311,453	104,183,000	52,091,500
Gross Profit	71,506,000	136,805,862	71,506,000	35,753,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	98,466,000	93,208,562	98,466,000	49,233,000
Operating Expenses	182,286,000	218,451,608	182,286,000	91,143,000
Operating Income	-110,780,000	-81,645,744	-110,780,000	-55,390,000
Interest Expense	0	8,639,417	6,953,000	0
Income Before Tax	-114,923,000	-136,869,777	-114,923,000	-57,461,500
Income Tax Expense	0	0	0	0
Net Income	-113,351,000	-134,034,876	-113,351,000	-56,675,500
Per Share
EPS	-0.11	-0.13	-0.11	-0.06
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Income Statement (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	536,806,723	257,249,000	104,592,000	21,603,000	2,150,000
Cost of Revenue	383,238,828	171,029,000	89,898,000	15,041,000	1,231,000
Gross Profit	153,567,894	86,220,000	14,694,000	6,562,000	919,000
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	165,144,323	263,216,000	364,789,000	354,514,000	230,163,000
Operating Expenses	347,032,777	574,971,000	989,831,000	1,105,351,000	611,102,000
Operating Income	-193,464,882	-488,751,000	-975,137,000	-1,098,789,000	-551,695,000
Interest Expense	19,296,320	21,506,000	18,408,000	11,126,000	5,293,000
Income Before Tax	-247,538,221	-647,101,000	-1,023,530,000	-1,146,284,000	-584,507,000
Income Tax Expense	0	0	0	20,506,000	0
Net Income	-243,198,521	-642,406,000	-1,012,174,000	-1,166,790,000	-582,921,000
Per Share
EPS	-0.23	-0.66	-1.06	-1.22	-0.61
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Balance Sheet (Quarterly)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Cash and Cash Equivalents	640,423,870	612,230,000	507,711,000	747,962,000
Short Term Investments	0	0	0	0
Net Receivables	263,874,843	44,389,000	4,969,000	1
Inventory	131,743,338	151,481,000	229,505,000	250,478,000
Total Current Assets	1,036,042,053	856,546,000	794,048,000	1,098,822,000
Property Plant Equipment	172,824,906	297,371,000	367,017,000	491,576,000
Goodwill and Intangibles	2,375,015	5,454,000	11,019,000	8,535,000
Total Assets	1,335,163,970	1,279,039,000	1,427,907,000	1,930,125,000
Liabilities
Account Payables	170,033,713	81,638,000	74,251,000	124,544,000
Short Term Debt	63,531,168	279,734,000	423,236,000	58,218,000
Total Current Liabilities	450,381,601	503,457,000	685,276,000	325,314,000
Long Term Debt	362,839,163	411,593,000	137,189,000	161,732,000
Total Liabilities	935,067,872	1,021,361,000	926,152,000	522,247,000
Shareholders Equity
Retained Earnings	0	-3,512,375,000	-2,869,969,000	-1,857,795,000
Total Shareholders Equity	410,849,695	278,202,000	519,480,000	1,417,658,000

Balance sheet annual history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Balance Sheet (Annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Assets
Cash and Cash Equivalents	640,423,870	612,230,000	507,711,000	747,962,000	1,940,825,000
Short Term Investments	0	0	0	0	0
Net Receivables	263,874,843	44,389,000	4,969,000	1	0
Inventory	131,743,338	151,481,000	229,505,000	250,478,000	109,881,000
Total Current Assets	1,036,042,053	856,546,000	794,048,000	1,098,822,000	2,094,226,000
Property Plant Equipment	172,824,906	297,371,000	367,017,000	491,576,000	361,000,000
Goodwill and Intangibles	2,375,015	5,454,000	11,019,000	8,535,000	4,556,000
Total Assets	1,335,163,970	1,279,039,000	1,427,907,000	1,930,125,000	2,791,884,000
Liabilities
Account Payables	170,033,713	81,638,000	74,251,000	124,544,000	83,601,000
Short Term Debt	63,531,168	279,734,000	423,236,000	58,218,000	52,863,000
Total Current Liabilities	450,381,601	503,457,000	685,276,000	325,314,000	234,469,000
Long Term Debt	362,839,163	411,593,000	137,189,000	161,732,000	151,813,000
Total Liabilities	935,067,872	1,021,361,000	926,152,000	522,247,000	401,732,000
Shareholders Equity
Retained Earnings	0	-3,512,375,000	-2,869,969,000	-1,857,795,000	0
Total Shareholders Equity	410,849,695	278,202,000	519,480,000	1,417,658,000	2,393,142,000

Cash flow quarterly history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Cash Flow Statement (Quarterly)	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Operating Activities
Net Income	-647,101,000	-1,023,530,000	-1,146,284,000	-582,921,000
Depreciation & Amortization	117,844,000	111,759,000	100,706,000	35,373,000
Stock Based Compensation	48,165,000	111,875,000	136,919,000	91,199,000
Change in Working Capital	16,490,000	104,020,000	-64,244,000	-80,709,000
Operating Cash Flow	-298,124,000	-567,843,000	-898,475,000	-540,486,000
Investing Activities
Capital Expenditure	-42,091,000	-66,454,000	-194,815,000	-133,979,000
Investments	-41,785,000	-64,985,000	-194,815,000	-130,996,000
Investing Cash Flow	-47,604,000	-58,385,000	-267,825,000	-396,575,000
Financing Activities
Debt Repayment	159,344,000	398,674,000	-20,000,000	0
Common Stock Issued/Repurchased	351,500,000	0	0	1,422,223,000
Dividends Paid	0	0	0	0
Financing Cash Flow	449,962,000	385,676,000	-27,946,000	1,392,245,000
Summary
Free Cash Flow	-340,215,000	-634,297,000	-1,093,290,000	-674,465,000
Net Change in Cash	104,519,000	-240,251,000	-1,192,863,000	443,499,000

Cash flow annual history for Shanghai MicroPort MedBot Group Co Ltd (2252.HK).
Cash Flow Statement (Annual)	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-647,101,000	-1,023,530,000	-1,146,284,000	-582,921,000	-208,874,000
Depreciation & Amortization	117,844,000	111,759,000	100,706,000	35,373,000	4,457,000
Stock Based Compensation	48,165,000	111,875,000	136,919,000	91,199,000	15,782,000
Change in Working Capital	16,490,000	104,020,000	-64,244,000	-80,709,000	31,948,000
Operating Cash Flow	-298,124,000	-567,843,000	-898,475,000	-540,486,000	-103,042,000
Investing Activities
Capital Expenditure	-42,091,000	-66,454,000	-194,815,000	-133,979,000	-15,011,000
Investments	-41,785,000	-64,985,000	-194,815,000	-130,996,000	-14,554,000
Investing Cash Flow	-47,604,000	-58,385,000	-267,825,000	-396,575,000	-15,008,000
Financing Activities
Debt Repayment	159,344,000	398,674,000	-20,000,000	0	-3,670,000
Common Stock Issued/Repurchased	351,500,000	0	0	1,422,223,000	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	449,962,000	385,676,000	-27,946,000	1,392,245,000	1,560,668,000
Summary
Free Cash Flow	-340,215,000	-634,297,000	-1,093,290,000	-674,465,000	-118,053,000
Net Change in Cash	104,519,000	-240,251,000	-1,192,863,000	443,499,000	1,442,618,000